학술논문
Rationale for and design of a multicenter, placebo-controlled, phase 3 study to assess efficacy and safety of intranasal etripamil for the conversion of paroxysmal supraventricular tachycardia
Document Type
Article
Author
Source
In: American Heart Journal . (American Heart Journal, November 2022, 253:20-29)
Subject
Language
English
ISSN
10976744
00028703
00028703